EchoIQ Limited ( (AU:EIQ) ) has provided an update.
Echo IQ has received $1.26 million under the Australian Government’s R&D Tax Incentive Scheme for the fiscal year ending June 30, 2024. This funding recognizes the company’s investment in R&D for AI innovations and decision-support solutions for detecting structural heart disease, supporting its operational growth and industry positioning.
More about EchoIQ Limited
Echo IQ is a Sydney-based AI and Medical Technology company that utilizes AI-driven technology and proprietary software to enhance decision-making in cardiology.
YTD Price Performance: 13.04%
Average Trading Volume: 1,626,527
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: A$150.1M
Learn more about EIQ stock on TipRanks’ Stock Analysis page.